Details for New Drug Application (NDA): 077019
The generic ingredient in CILOSTAZOL is cilostazol. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the cilostazol profile page.
Summary for 077019
| Tradename: | CILOSTAZOL |
| Applicant: | Aurobindo Pharma Usa |
| Ingredient: | cilostazol |
| Patents: | 0 |
Pharmacology for NDA: 077019
| Mechanism of Action | Phosphodiesterase 3 Inhibitors |
Suppliers and Packaging for NDA: 077019
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CILOSTAZOL | cilostazol | TABLET;ORAL | 077019 | ANDA | Aurobindo Pharma Limited | 84386-002 | 84386-002-60 | 60 TABLET in 1 BOTTLE (84386-002-60) |
| CILOSTAZOL | cilostazol | TABLET;ORAL | 077019 | ANDA | Aurobindo Pharma Limited | 84386-003 | 84386-003-60 | 60 TABLET in 1 BOTTLE (84386-003-60) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Nov 23, 2004 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Nov 23, 2004 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
